Humacyte, Inc. Warrant (HUMAW)
Since Aug 12, 2022, Humacyte, Inc. Warrant (HUMAW) has reported earnings 16 times. On average the shares move ±3.72% post-earnings, with a positive reaction 93.8% of the time. Its largest post-earnings gain was +12% (Aug 12, 2022) and its largest decline was -38.95% (Aug 11, 2025). The next earnings report is predicted for 2026-11-10 (estimated).
Earnings reactions
How HUMAW moved on each past earnings report.
Earnings Impact
Total Earnings
16
Avg Abs. Movement
±3.72%
Positive %
93.8%
Negative %
6.2%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| Aug 12, 2026 | ☀ PRE | +0% | open_in_new |
| Mar 19, 2026 | ☀ PRE | +0% | open_in_new |
| Nov 12, 2025 | ☀ PRE | +0% | open_in_new |
| Aug 11, 2025 | ☀ PRE | -38.95% | open_in_new |
Earnings Count
16
Total earnings in dataset
Avg Abs. Movement
±3.72%
Avg % price change on earnings
Institutional ownership
Holdings as of Jun 30, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 25-NSE | 20260825 | open_in_new SEC.gov |
| 4 | 20260821 | open_in_new SEC.gov |
| 4 | 20260819 | open_in_new SEC.gov |
| SCHEDULE 13D/A | 20260818 | open_in_new SEC.gov |
| 10-Q | 20260812 | open_in_new SEC.gov |
| 8-K | 20260812 | open_in_new SEC.gov |
| 8-K | 20260731 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260728 | open_in_new SEC.gov |
| SCHEDULE 13D/A | 20260713 | open_in_new SEC.gov |
| SCHEDULE 13G | 20260622 | open_in_new SEC.gov |
Frequently asked about HUMAW earnings
When does Humacyte, Inc. Warrant report earnings next? expand_more
Humacyte, Inc. Warrant (HUMAW)'s next earnings date is estimated for 2026-11-10. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does HUMAW stock move after earnings? expand_more
Over 16 reports, HUMAW has moved an average of ±3.72% the session after earnings, closing higher 93.8% of the time.
What was HUMAW's biggest post-earnings move? expand_more
HUMAW's largest post-earnings gain on record was +12% on Aug 12, 2022, and its largest decline was -38.95% on Aug 11, 2025.
Where can I find Humacyte, Inc. Warrant's SEC filings? expand_more
All of Humacyte, Inc. Warrant's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right